Incyte Provides Regulatory Update on Ruxolitinib Extended-Release Tablets
NeuroSense Therapeutics to collaborate with Massachusetts General Hospital's NeuroEpigenetics Lab
DermBiont Touts Phase 2 Trial Data Treating Seborrheic Keratosis with SM-020 Topical Gel
Athersys Reports on Type B Meeting with the US FDA
Incyte receives Japanese approval for Pemazyre to treat myeloid/lymphoid neoplasms
Pharming Group's Joenja receives FDA approval to treat APDS
Josep Bassaganya-Riera Launches NImmune Biopharma
ONO Pharma USA's Tirabrutinib (ONO-4059) receives FDA Orphan Drug Designation